JPH05237162A - Liquid chemical container housing body - Google Patents
Liquid chemical container housing bodyInfo
- Publication number
- JPH05237162A JPH05237162A JP4315634A JP31563492A JPH05237162A JP H05237162 A JPH05237162 A JP H05237162A JP 4315634 A JP4315634 A JP 4315634A JP 31563492 A JP31563492 A JP 31563492A JP H05237162 A JPH05237162 A JP H05237162A
- Authority
- JP
- Japan
- Prior art keywords
- container
- oxygen
- liquid chemical
- liquid medicine
- packaging
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000126 substance Substances 0.000 title claims abstract description 91
- 239000007788 liquid Substances 0.000 title claims abstract description 69
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims abstract description 66
- 239000001301 oxygen Substances 0.000 claims abstract description 66
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 66
- 238000004806 packaging method and process Methods 0.000 claims abstract description 35
- 239000011261 inert gas Substances 0.000 claims abstract description 20
- 239000000463 material Substances 0.000 claims abstract description 13
- 230000006866 deterioration Effects 0.000 claims abstract description 10
- 239000007789 gas Substances 0.000 claims abstract description 10
- 239000003814 drug Substances 0.000 claims description 58
- 229940079593 drug Drugs 0.000 claims description 34
- 229940123973 Oxygen scavenger Drugs 0.000 claims description 26
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 claims description 17
- 239000006096 absorbing agent Substances 0.000 claims description 17
- 229910001882 dioxygen Inorganic materials 0.000 claims description 17
- 238000003860 storage Methods 0.000 claims description 9
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 6
- 229920002457 flexible plastic Polymers 0.000 claims description 6
- 230000004888 barrier function Effects 0.000 claims description 4
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 3
- 239000001569 carbon dioxide Substances 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 abstract description 42
- 238000004659 sterilization and disinfection Methods 0.000 abstract description 42
- 229920003023 plastic Polymers 0.000 abstract description 16
- 239000004033 plastic Substances 0.000 abstract description 16
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract description 14
- 230000035699 permeability Effects 0.000 abstract description 9
- 239000003795 chemical substances by application Substances 0.000 abstract description 5
- 229920001971 elastomer Polymers 0.000 abstract description 4
- 229910052757 nitrogen Inorganic materials 0.000 abstract description 4
- 239000005060 rubber Substances 0.000 abstract description 4
- 238000002347 injection Methods 0.000 abstract description 3
- 239000007924 injection Substances 0.000 abstract description 3
- 229920001684 low density polyethylene Polymers 0.000 abstract description 2
- 239000004702 low-density polyethylene Substances 0.000 abstract description 2
- 239000002985 plastic film Substances 0.000 abstract description 2
- 229920006255 plastic film Polymers 0.000 abstract description 2
- 238000007789 sealing Methods 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 77
- 238000000034 method Methods 0.000 description 24
- 239000005022 packaging material Substances 0.000 description 24
- -1 polypropylene Polymers 0.000 description 13
- 239000005001 laminate film Substances 0.000 description 12
- 229920000219 Ethylene vinyl alcohol Polymers 0.000 description 9
- 229910001873 dinitrogen Inorganic materials 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 239000004743 Polypropylene Substances 0.000 description 7
- 229920001155 polypropylene Polymers 0.000 description 7
- 238000001816 cooling Methods 0.000 description 6
- 238000001802 infusion Methods 0.000 description 6
- 229920000092 linear low density polyethylene Polymers 0.000 description 6
- 239000004707 linear low-density polyethylene Substances 0.000 description 6
- 239000004698 Polyethylene Substances 0.000 description 5
- 229920001328 Polyvinylidene chloride Polymers 0.000 description 5
- 229920000573 polyethylene Polymers 0.000 description 5
- 239000005033 polyvinylidene chloride Substances 0.000 description 5
- 229910052782 aluminium Inorganic materials 0.000 description 4
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 238000007689 inspection Methods 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 229920005989 resin Polymers 0.000 description 4
- 239000011347 resin Substances 0.000 description 4
- 230000004075 alteration Effects 0.000 description 3
- 229920006378 biaxially oriented polypropylene Polymers 0.000 description 3
- 239000011127 biaxially oriented polypropylene Substances 0.000 description 3
- 230000002093 peripheral effect Effects 0.000 description 3
- 239000012466 permeate Substances 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 2
- 239000004952 Polyamide Substances 0.000 description 2
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 2
- 239000000498 cooling water Substances 0.000 description 2
- 238000007599 discharging Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000005038 ethylene vinyl acetate Substances 0.000 description 2
- 239000003978 infusion fluid Substances 0.000 description 2
- 239000002960 lipid emulsion Substances 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 2
- ZQBAKBUEJOMQEX-UHFFFAOYSA-N phenyl salicylate Chemical compound OC1=CC=CC=C1C(=O)OC1=CC=CC=C1 ZQBAKBUEJOMQEX-UHFFFAOYSA-N 0.000 description 2
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 2
- 229920002647 polyamide Polymers 0.000 description 2
- 229920000915 polyvinyl chloride Polymers 0.000 description 2
- 239000004800 polyvinyl chloride Substances 0.000 description 2
- 230000002000 scavenging effect Effects 0.000 description 2
- 230000009471 action Effects 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
- 239000012965 benzophenone Substances 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000005587 bubbling Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000008155 medical solution Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910001507 metal halide Inorganic materials 0.000 description 1
- 150000005309 metal halides Chemical class 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 229920006284 nylon film Polymers 0.000 description 1
- 235000016236 parenteral nutrition Nutrition 0.000 description 1
- 229960000969 phenyl salicylate Drugs 0.000 description 1
- 229920006122 polyamide resin Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920006267 polyester film Polymers 0.000 description 1
- 229920005672 polyolefin resin Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 238000002834 transmittance Methods 0.000 description 1
- 239000012780 transparent material Substances 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
Landscapes
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は、薬液容器収納体に関す
る。特に、高圧蒸気滅菌及び長期に渡って薬液の変質す
ることのない薬液容器収納体に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a drug solution container housing. In particular, it relates to high-pressure steam sterilization and a container for a liquid medicine container that does not deteriorate the liquid medicine for a long period of time.
【0002】[0002]
【従来の技術】近年、輸液等の医療において、内容液が
外界と接触することを防止するためにクローズドシテス
ムが用いられるようになってきている。このクローズド
シテスムに用いられる医療用の薬液入り容器は、重力と
容器の構造と容器の素材の柔軟性によって内容液を排出
することが必要である。また、この種の医療用の薬液入
り容器は、内容液を滅菌するために高圧蒸気滅菌に耐え
る耐熱性を有する必要がある。さらに内容液を外部から
監視できるように、透明な材料で形成されていることが
好ましい。従来の薬液入り容器は、ガラス瓶やガラスア
ンプルが中心であったが、クローズドシテスムに用いる
ことができるようにプラスチック製の薬液入り容器が市
場に出ている。2. Description of the Related Art In recent years, in medical treatment such as infusion, a closed system has been used in order to prevent the content liquid from coming into contact with the outside world. The medical solution container for medical use used in this closed system needs to discharge the content liquid due to gravity, the structure of the container, and the flexibility of the material of the container. Further, this type of medical liquid container is required to have heat resistance to withstand high-pressure steam sterilization in order to sterilize the content liquid. Further, it is preferably made of a transparent material so that the content liquid can be monitored from the outside. Conventional containers containing chemicals have been glass bottles and glass ampoules, but plastic containers containing chemicals have been put on the market so that they can be used in closed systems.
【0003】[0003]
【発明が解決しようとする課題】この種の薬液入りプラ
スチック容器は、内容液を滅菌するために通常は高圧蒸
気滅菌される。常温では、ガス透過性が低いプラスチッ
ク材料、例えばポリ塩化ビニルでも高圧蒸気滅菌時には
ガス透過性が高くなり、雰囲気内に存在する酸素がプラ
スチック材料で形成された容器壁を通って容器内に侵入
しやすくなる。また、常温においてもプラスチック容器
は、ガラス瓶やガラスアンプルに比べて、ガス透過性が
高いのでプラスチック容器をガスバリヤー性の高い包装
材料で包装しているが、それでも長期間保存しておくと
その雰囲気内に存在する酸素が徐々に容器壁を透過し容
器内に侵入してくる。容器内の薬液が、トリプトファン
を含む高濃度アミノ酸輸液剤や輸液用脂肪乳剤や酸素の
存在により酸化あるいは加水分解されやすい抗生物質を
含む輸液剤等の酸素によって酸化等による変質が起こり
やすい成分を含む場合には変質や変色の恐れが多い。A plastic container containing a chemical solution of this kind is usually subjected to high-pressure steam sterilization to sterilize the content solution. At room temperature, even plastic materials with low gas permeability, such as polyvinyl chloride, will have high gas permeability during high-pressure steam sterilization, and oxygen existing in the atmosphere will enter the container through the container wall formed of the plastic material. It will be easier. Also, even at room temperature, plastic containers have higher gas permeability than glass bottles and glass ampoules, so plastic containers are packed with a packaging material with a high gas barrier property, but even if they are stored for a long period of time, the atmosphere will change. Oxygen existing inside penetrates the container wall gradually and enters the container. The drug solution in the container contains high-concentration amino acid infusion containing tryptophan, fat emulsion for infusion, and infusions containing antibiotics that are easily oxidized or hydrolyzed by the presence of oxygen. In many cases, there is a risk of deterioration and discoloration.
【0004】[0004]
【課題を解決するための手段】耐熱性を有する柔軟なプ
ラスチック材料で形成された少なくとも一つ以上の排出
口を有する容器内に酸素によって変質しやすい成分を含
む薬液が容器内と薬液中の酸素を不活性ガスで置換した
状態で充填されている薬液容器を、脱酸素剤とともに、
高い酸素ガス非透過性と耐熱性と透明性を有する包装容
器に少なくとも前記脱酸素剤の周囲に空間が存在するよ
うに封入してなり、前記薬液容器の外側と前記包装容器
の内側で構成される空間自体が薬液容器内への酸素透過
を防ぐ実質的に無酸素状態のバリアー層をなし、かつ、
少なくとも薬液容器が高圧蒸気滅菌処理されていること
を特徴とする薬液の変質を高度に防止する薬液容器収容
体を提供することにより前記問題点を解決した。[MEANS FOR SOLVING THE PROBLEMS] In a container having at least one discharge port formed of a flexible plastic material having heat resistance, a chemical solution containing a component which is easily deteriorated by oxygen is oxygen in the container and in the chemical solution. The chemical solution container filled with the inert gas replaced with the oxygen absorber,
It is enclosed in a packaging container having high oxygen gas impermeability, heat resistance and transparency so that there is a space around at least the oxygen scavenger, and is constituted by the outside of the liquid medicine container and the inside of the packaging container. The space itself forms a barrier layer in a substantially oxygen-free state that prevents oxygen permeation into the liquid medicine container, and
The above-mentioned problems have been solved by providing a drug solution container container for highly preventing deterioration of a drug solution, which is characterized in that at least the drug solution container is subjected to high-pressure steam sterilization.
【0005】[0005]
【作用】本発明者らは、高圧蒸気滅菌時及び滅菌後も長
期に渡って薬液が変質することがない薬液容器収納体を
開発すべく種々検討した結果、耐熱性を有する柔軟なプ
ラスチック材料で形成された少なくとも一つ以上の排出
口を有する容器に薬液を入れたものと脱酸素剤をとも
に、少なくとも前記脱酸素剤の周囲に空間が存在するよ
うに耐熱性と高い酸素ガス非透過性を有する包装容器に
封入することにより、高圧蒸気滅菌時に包装材料が酸素
を透過しやすい状態になっても薬液が変質することがな
いこと、また、滅菌後も長期に渡って薬液が変質するこ
とがないこと等を見い出し本発明を完成するに至った。The inventors of the present invention have conducted various studies to develop a drug solution container container in which the drug solution does not deteriorate during and after high-pressure steam sterilization, and as a result, a flexible plastic material having heat resistance was used. Both the container containing the chemical solution and the oxygen scavenger formed in at least one or more outlets are provided with heat resistance and high oxygen gas impermeability so that at least a space exists around the oxygen absorber. By enclosing it in the packaging container that it has, the chemical solution does not deteriorate even if the packaging material becomes easily permeable to oxygen during high-pressure steam sterilization, and the chemical solution deteriorates for a long period after sterilization. The inventors have found that there is nothing and have completed the present invention.
【0006】本発明の薬液容器は、高圧蒸気滅菌に供さ
れるから、滅菌の温度に耐え得る耐熱性を有する柔軟な
プラスチック材料で形成する必要がある。さらに、強
度、耐水蒸気透過性及び透明性に優れていることが好ま
しい。このような条件を満足するプラスチック材料に
は、軟質ポリ塩化ビニル、架橋されたエチレン−酢酸ビ
ニル共重合体、直鎖状低密度ポリエチレン等が含まれ
る。Since the drug solution container of the present invention is subjected to high-pressure steam sterilization, it must be formed of a flexible plastic material having heat resistance capable of withstanding the sterilization temperature. Further, it is preferable that it has excellent strength, water vapor permeation resistance and transparency. Plastic materials satisfying such conditions include soft polyvinyl chloride, crosslinked ethylene-vinyl acetate copolymer, linear low density polyethylene and the like.
【0007】上記プラスチック容器に収容される酸素に
よって変質しやすい成分を含む薬液には、少なくとも一
種の高カロリー液剤成分(経中心静脈栄養成分)特にト
リプトファンを含む高濃度アミノ酸輸液剤や脂肪乳剤、
また酸素の存在により酸化あるいは加水分解されやすい
抗生物質を含む輸液剤等が含まれる。The drug solution containing a component which is easily deteriorated by oxygen contained in the above-mentioned plastic container includes a high concentration amino acid infusion solution and a fat emulsion containing at least one high calorie solution component (transparental parenteral nutrition component), especially tryptophan,
Also included are infusions containing antibiotics that are easily oxidized or hydrolyzed by the presence of oxygen.
【0008】上記プラスチック容器に前記薬液を分注す
る。このとき、容器内及び薬液中を不活性ガスで置換し
て実質的に容器内及び薬液中に酸素が存在しないように
して封をするのが好ましい。例えば、プラスチック容器
に薬液を注入後、薬液内に不活性ガスをバブリングする
ことにより容器内及び薬液中に酸素が存在しないように
する方法でもよいし、また、予め不活性ガスで置換され
た薬液を不活性ガスと共に注入し、容器内及び薬液中に
酸素が存在しないようにする方法でもよい。また、用い
られる不活性ガスは種々あるが、コストの面から窒素ガ
スが好ましい。The chemical solution is dispensed into the plastic container. At this time, it is preferable to replace the inside of the container and the chemical liquid with an inert gas so that oxygen is not substantially present in the container and the chemical liquid, and the container is sealed. For example, after injecting a chemical solution into a plastic container, a method of bubbling an inert gas into the chemical solution so that oxygen does not exist in the container and the chemical solution, or a chemical solution previously replaced with an inert gas may be used. May be injected together with an inert gas so that oxygen does not exist in the container and in the chemical solution. Although there are various inert gases used, nitrogen gas is preferable from the viewpoint of cost.
【0009】次に、上記薬液容器を脱酸素剤とともに少
なくとも前記脱酸素剤の周囲に空間が存在するように、
耐熱性と高い酸素ガス非透過性を有する包装材料で包装
する(即ち、包装容器に封入する。)。前記脱酸素剤を
その周囲に空間が存在しないように包装材料で包装する
と、脱酸素剤の酸素除脱効果が悪くなり、高圧蒸気滅菌
時または保存時に、上記薬液容器内の薬液が酸素により
変質しやすくなる。前記脱酸素剤の周囲に空間を存在さ
せる方法は、上記薬液容器と脱酸素剤を包装容器に入れ
るとき、空気や不活性ガス等を入れる方法や、脱酸素剤
を片面から他面に連通する孔を有する構造体で覆う方法
や、凹凸を有する板の上に脱酸素剤と薬液容器を位置さ
せ包装容器に入れる方法や、包装容器に凸部を設ける方
法や、トレー部とシート状蓋体から構成される包装容器
を用いる方法等がある。Next, the chemical liquid container is placed together with the oxygen scavenger so that a space exists at least around the oxygen scavenger.
Wrap with a packaging material that has heat resistance and high oxygen gas impermeable properties (ie, enclose in a packaging container). If the oxygen scavenger is packed with a packaging material so that there is no space around it, the oxygen scavenging effect of the oxygen scavenger deteriorates, and the chemical liquid in the chemical liquid container is altered by oxygen during high-pressure steam sterilization or storage. Easier to do. The method of allowing a space to exist around the oxygen scavenger is, when the chemical solution container and the oxygen scavenger are put in a packaging container, a method of introducing air or an inert gas, or communicating the oxygen scavenger from one surface to the other surface. A method of covering with a structure having holes, a method of placing an oxygen absorber and a chemical solution container on a plate having irregularities and placing it in a packaging container, a method of providing a convex portion on the packaging container, a tray part and a sheet-like lid There is a method of using a packaging container composed of.
【0010】また、脱酸素剤を用いる量は、高圧蒸気滅
菌時及び長期保存中に、薬液中において、薬液の酸素で
の酸化等による変質が起こらない酸素濃度を保つことが
できる量が必要である。例えば、400mlの高濃度ア
ミノ酸輸液剤を入れた薬液容器の場合は、酸素吸収量が
10ml以上が必要であり、酸素吸収量が100ml以
上の脱酸素剤を用いることが好ましい。Further, the amount of the oxygen scavenger used is required to be an amount capable of maintaining an oxygen concentration in the chemical liquid during high-pressure steam sterilization and during long-term storage, which does not cause deterioration due to oxidation of the chemical liquid by oxygen or the like. is there. For example, in the case of a liquid medicine container containing 400 ml of a high-concentration amino acid transfusion, an oxygen absorption amount of 10 ml or more is required, and it is preferable to use a deoxidizer having an oxygen absorption amount of 100 ml or more.
【0011】前記脱酸素剤としては、鉄等の金属および
ハロゲン化金属からなる粉末状のもの、アスコルピン酸
やカテコールを主剤とした有機系のものが知られてい
る。これらの脱酸素剤は、三菱瓦斯化学(株)[商品
名:エージレス]やその他のメーカー数社から市販され
ている。これら脱酸素剤のなかには、酸素吸収のみを行
うものと、酸素吸収と同時に炭酸ガスを放出するものが
ある。トレー部とシート状蓋体から構成される包装容器
を用いるときには、酸素吸収と同時に炭酸ガスを放出す
る脱酸素剤を用いるのが好ましい。すなわち、脱酸素剤
により包装容器内の酸素を除脱すると包装容器内の圧が
下がり、ピンホールの発生等の問題が生じる危険性があ
るので、酸素吸収と同時に炭酸ガスを放出すれば包装容
器内の圧力を一定に保つことができるからである。As the oxygen scavenger, powdery ones made of a metal such as iron and a metal halide, and organic ones mainly containing ascorbic acid or catechol are known. These oxygen scavengers are commercially available from Mitsubishi Gas Chemical Co., Inc. [trade name: Ageless] and several other manufacturers. Among these oxygen absorbers, there are one that only absorbs oxygen and one that releases carbon dioxide at the same time as oxygen is absorbed. When a packaging container composed of a tray portion and a sheet-like lid is used, it is preferable to use a deoxidizing agent that releases carbon dioxide at the same time as absorbing oxygen. In other words, if oxygen is removed from the packaging container with an oxygen scavenger, the pressure inside the packaging container will drop, which may cause problems such as pinholes. This is because the internal pressure can be kept constant.
【0012】また、脱酸素剤の作用としては、前記包装
容器を透過した酸素を除脱し薬液容器内に酸素が侵入し
ないようにする作用と、高圧蒸気滅菌前に薬液容器内と
薬液中の酸素を薬液容器壁を経て除脱する作用がある。The oxygen scavenger acts to remove oxygen that has permeated the packaging container so that oxygen does not enter the chemical solution container, and oxygen in the chemical solution container and the chemical solution before high-pressure steam sterilization. There is an action of removing the chemicals through the wall of the liquid medicine container.
【0013】前記耐熱性と高い酸素ガス非透過性を有す
る包装容器の材料は、エチレン−ビニルアルコール共重
合体フィルムやポリ塩化ビニリデンフィルムの層を有す
る三層ラミネートフィルムやアルミニウム層を有するラ
ミネートフィルムがある。アルミニウム層を有するラミ
ネートフィルムは不透明であるが、その酸素ガス非透過
性能は湿度による影響を受けない。また、前記合成樹脂
製の三層ラミネートフィルムは、透明であるので包装材
料内の薬液の異物検査や変質度合いの検査等を容易に行
うことができるが、その酸素ガス非透過性能は湿度によ
る影響を受けやすい。そこで、上記薬液容器を包装容器
に封入後、高圧蒸気滅菌するときには、この三層ラミネ
ートフィルムの外層は、ポリアミド樹脂等の耐熱性があ
り比較的水蒸気透過性の高い樹脂をラミネートすること
が好ましい。すなわち、後述の高圧蒸気滅菌時に中間層
のエチレン−ビニルアルコール共重合体フィルムやポリ
塩化ビニリデンフィルムの層が吸湿し酸素ガスを透過し
やすくなるので、外層に比較的水蒸気透過性の高い樹脂
を用いることにより短時間で吸湿した水分を蒸散させや
すくすることができ、その結果短時間でもとの高い酸素
ガス非透過性に復元するからである。この三層ラミネー
トフィルムの内層には、水蒸気透過性の低い樹脂をラミ
ネートすることが好ましい。すなわち、上記薬液容器内
の薬液が容器壁を透過しても、このシートの内層が水蒸
気透過性の低い樹脂であれば、中間層のエチレン−ビニ
ルアルコール共重合体フィルムやポリ塩化ビニリデンフ
ィルムがほとんど吸湿することがなく、この包装容器は
高い酸素ガス非透過性を保つことができるからである。
この内層には未延伸ポリプロピレンフィルムや未延伸ポ
リエチレンフィルムをラミネートすることが好ましく、
熱溶着性が良好となる。The material of the packaging container having heat resistance and high oxygen gas impermeability is a three-layer laminate film having an ethylene-vinyl alcohol copolymer film or a polyvinylidene chloride film layer or a laminate film having an aluminum layer. is there. Although the laminated film having the aluminum layer is opaque, its oxygen gas impermeable performance is not affected by humidity. In addition, since the three-layer laminate film made of synthetic resin is transparent, it is possible to easily perform foreign matter inspection and inspection of the degree of alteration of the chemical liquid in the packaging material, but its oxygen gas impermeable performance is affected by humidity. It is easy to receive. Therefore, when high-pressure steam sterilization is performed after the above-mentioned chemical solution container is sealed in a packaging container, the outer layer of this three-layer laminate film is preferably laminated with a resin having heat resistance and relatively high water vapor permeability, such as polyamide resin. That is, during high-pressure steam sterilization to be described later, since the layer of the ethylene-vinyl alcohol copolymer film or polyvinylidene chloride film of the intermediate layer absorbs moisture easily and oxygen gas easily permeates, a resin having relatively high water vapor permeability is used for the outer layer. This is because moisture absorbed can be easily evaporated in a short time, and as a result, the high oxygen gas impermeable property can be restored in a short time. A resin having low water vapor permeability is preferably laminated on the inner layer of the three-layer laminate film. That is, even if the liquid medicine in the liquid medicine container permeates the container wall, if the inner layer of this sheet is a resin having low water vapor permeability, the ethylene-vinyl alcohol copolymer film or polyvinylidene chloride film of the intermediate layer is almost the same. This is because this packaging container can maintain high oxygen gas impermeable property without absorbing moisture.
It is preferable to laminate an unstretched polypropylene film or an unstretched polyethylene film on this inner layer,
Good thermal weldability.
【0014】さらに、高圧蒸気滅菌後、オーブン等の乾
燥機内で前述の三層ラミネートフィルムが吸湿した水分
を積極的に蒸散させることが好ましい。さらに、前述の
乾燥を不活性ガス雰囲気中で行うのがより好ましい。す
なわち、三層ラミネートフィルムの酸素ガス非透過性が
短時間で復元するので、薬液の酸素での酸化等による変
質を、より確実に、より長時間防止することができる。Further, after high-pressure steam sterilization, it is preferable to actively evaporate the moisture absorbed by the above-mentioned three-layer laminate film in a dryer such as an oven. Furthermore, it is more preferable to perform the above-mentioned drying in an inert gas atmosphere. That is, since the oxygen gas impermeability of the three-layer laminate film is restored in a short time, it is possible to more reliably prevent the chemical liquid from being deteriorated due to oxidation with oxygen or the like for a longer time.
【0015】また、上述の三層ラミネートフィルムを包
装容器の片面に、あるいはトレー部とシート状蓋体から
構成される包装容器にあっては該三層ラミネートフィル
ムをトレー部またはシート状蓋体に用い、一方他の面あ
るいはトレー部またはシート状蓋体の残部には上述のエ
チレン−ビニルアルコール共重合体フィルムのかわりに
アルミニウム層を有するラミネートフィルムを用いても
よい。このようにすれば、包装容器の片面あるいはトレ
ー部またはシート状蓋体のどちらか一方が透明になるの
で、包装容器内の薬液の異物検査や変質度合いの検査等
を容易に行うことができ、また酸素ガス非透過性能の湿
度による影響を少なくすることができる。Further, the above-mentioned three-layer laminated film is used on one side of a packaging container, or in the case of a packaging container composed of a tray part and a sheet-like lid, the three-layer laminated film is formed on the tray part or the sheet-like lid. On the other hand, a laminated film having an aluminum layer may be used in place of the above-mentioned ethylene-vinyl alcohol copolymer film on the other surface or the rest of the tray part or the sheet-like lid. In this way, since either one side of the packaging container or the tray portion or the sheet-like lid body becomes transparent, it is possible to easily perform the foreign substance inspection and the alteration degree inspection of the chemical liquid in the packaging container, Moreover, the influence of humidity on the oxygen gas impermeable performance can be reduced.
【0016】また、上述の透明な三層ラミネートフィル
ムを用いる場合、薬液によっては紫外線によって変質し
やすいものがあるので、三層ラミネートフィルムの少な
くとも一層には、ベンゾフェノン系やサリチル酸フェニ
ル系等の紫外線吸収剤を含有させたり、あるいは紫外線
を透過させにくくするために着色したりすることが好ま
しい。Further, when the above-mentioned transparent three-layer laminate film is used, some chemicals are likely to be deteriorated by ultraviolet rays. Therefore, at least one layer of the three-layer laminate film absorbs ultraviolet rays of benzophenone type or phenyl salicylate type. It is preferable to add an agent or to color it in order to make it difficult to transmit ultraviolet rays.
【0017】次に、上記のごとく包装材料で包装した薬
液容器収納体を高圧蒸気滅菌する。滅菌方法としては、
オートクレーブ、タワーオートクレーブ、ロートマット
等が用いられる。高圧蒸気滅菌時にその雰囲気中に酸素
ガスが存在し前記包装材料が酸素ガスを透過しやすい状
態にあっても、前記脱酸素剤によって前記包装材料を透
過した酸素を除脱するので、プラスチック容器内の薬液
は酸素によって変質することはない。また、オートクレ
ーブの場合、高圧蒸気滅菌時の圧力をその雰囲気中に不
活性ガスを導入することによって維持することがより好
ましい。タワーオートクレーブ及びロートマットの場
合、水中を不活性ガスで置換し酸素が実質的に存在しな
い状態にすることがより好ましい。用いる不活性ガスは
窒素ガスが好ましい。Next, the container for the liquid medicine container packaged with the packaging material as described above is subjected to high-pressure steam sterilization. As a sterilization method,
An autoclave, a tower autoclave, a funnel mat, etc. are used. Even if oxygen gas is present in the atmosphere during high-pressure steam sterilization and the packaging material is in a state where oxygen gas easily permeates, the oxygen that has permeated the packaging material is removed by the oxygen scavenger. The chemical solution of is not altered by oxygen. Further, in the case of an autoclave, it is more preferable to maintain the pressure during high-pressure steam sterilization by introducing an inert gas into the atmosphere. In the case of a tower autoclave and a funnel mat, it is more preferable to replace water with an inert gas so that oxygen is substantially absent. The inert gas used is preferably nitrogen gas.
【0018】このようにして製造された薬液容器収納体
は、薬液容器内の薬液は実質的に無酸素状態でかつ滅菌
されており、更に、薬液容器と包装容器の間の空間は実
質的に無酸素状態でかつ滅菌されたバリアー層となって
いるため、長期間の保存においても内部の薬液の酸素で
の酸化等による変質が殆ど起こらない。In the drug solution container housing thus manufactured, the drug solution in the drug solution container is substantially anoxic and sterilized, and the space between the drug solution container and the packaging container is substantially Since it is an oxygen-free and sterilized barrier layer, even if it is stored for a long period of time, the deterioration due to the oxidation of the internal chemical liquid by oxygen or the like hardly occurs.
【0019】また、別の方法で酸素による薬液の変質を
防止する薬液容器収納体を製造することができる。ま
ず、上記のように薬液容器を作製する。次に、この薬液
容器を高圧蒸気滅菌する。滅菌方法としては、前述のよ
うにオートクレーブ、タワーオートクレーブ及びロート
マット等が用いられる。オートクレーブの場合、高圧蒸
気滅菌時及び滅菌後の冷却時の圧力をその雰囲気中に不
活性ガスを導入することによって維持する。タワーオー
トクレーブ及びロートマットの場合、水中を不活性ガス
で置換し、薬液容器内に酸素が侵入しないようにする。
用いる不活性ガスは窒素ガスが好ましい。In addition, it is possible to manufacture a liquid medicine container housing for preventing the deterioration of the liquid medicine by oxygen by another method. First, the chemical solution container is manufactured as described above. Next, this chemical solution container is subjected to high-pressure steam sterilization. As a sterilization method, an autoclave, a tower autoclave, a funnel mat, or the like is used as described above. In the case of an autoclave, the pressure during autoclave sterilization and cooling after sterilization is maintained by introducing an inert gas into the atmosphere. For tower autoclaves and funnel mats, replace water with an inert gas to prevent oxygen from entering the chemical solution container.
The inert gas used is preferably nitrogen gas.
【0020】滅菌後、上記薬液容器を脱酸素剤ととも
に、少なくとも前記脱酸素剤の周囲に空間が存在するよ
うに、高い酸素ガス非透過性を有する包装材料で包装す
る。脱酸素剤をその周囲に空間が存在しないように包装
材料で包装すると、前述のように脱酸素剤の酸素除脱効
果が悪くなり、滅菌後の保存時に薬液容器内の薬液が酸
素での酸化等による変質が起こりやすくなる。また、前
記脱酸素剤の周囲に空間を存在させる方法は、前述のよ
うに上記薬液容器と脱酸素剤を包装材料に入れるとき
に、同時に空気や不活性ガスを入れる方法や、脱酸素剤
を片面から他面に連通する孔を有する構造体で覆う方法
や、凹凸を有する板の上に脱酸素剤と薬液容器を乗せ包
装材料に入れる方法や、包装材料に凸部を設ける方法
や、トレー部とシート状蓋体から構成される包装材料を
用いる方法等がある。After sterilization, the chemical solution container is packaged together with the oxygen scavenger in a packaging material having a high oxygen gas impermeable property so that a space exists at least around the oxygen scavenger. If the oxygen scavenger is packed with packaging material so that there is no space around it, the oxygen scavenging effect of the oxygen scavenger deteriorates, as described above, and the chemical solution in the chemical solution container is oxidized by oxygen during storage after sterilization. Deterioration due to, for example, is likely to occur. Further, as a method for allowing a space to exist around the oxygen absorber, as described above, when the chemical solution container and the oxygen absorber are put into the packaging material, a method of simultaneously introducing air or an inert gas, or an oxygen absorber is used. A method of covering with a structure having holes that communicate from one side to the other side, a method of placing an oxygen absorber and a chemical solution container on a plate with unevenness and placing it in the packaging material, a method of providing a convex portion on the packaging material, and a tray. There is a method of using a packaging material composed of a portion and a sheet-like lid.
【0021】前記高い酸素ガス非透過性を有する包装材
料には、エチレン−ビニルアルコール共重合体フィルム
やポリ塩化ビニリデンフィルムの層を有する三層ラミネ
ートフィルムや、アルミニウム層を有するラミネートフ
ィルムがある。透明性を有する三層ラミネートフィルム
では、エチレン−ビニルアルコール共重合体フィルムの
内層には、未延伸のポリプロピレンフィルムや未延伸ポ
リエチレンフィルムをラミネートすることが好ましく熱
融着性が良好となる。さらにエチレン−ビニルアルコー
ル共重合体フィルムの外層には、外部雰囲気中の水分の
影響を少なくするために、二軸延伸ポリプロピレンフィ
ルム、ポリエチレンフィルム等をラミネートすることが
好ましい。また、ポリエチレン、ポリプロピレン等のオ
レフィン系樹脂、ポリエステル、ポリウレタン、ポリア
ミド等の厚みの大きな包装材料を用いることもできる。
この方法によれば、プラスチック容器の原料として包装
材料とブロッキングが起こりやすい架橋されたエチレン
−酢酸ビニル共重合体を用いることができる。Examples of the packaging material having high impermeability to oxygen gas include a three-layer laminate film having layers of an ethylene-vinyl alcohol copolymer film and a polyvinylidene chloride film, and a laminate film having an aluminum layer. In a three-layer laminated film having transparency, it is preferable to laminate an unstretched polypropylene film or unstretched polyethylene film on the inner layer of the ethylene-vinyl alcohol copolymer film, and the heat fusion property becomes good. Further, it is preferable to laminate a biaxially oriented polypropylene film, a polyethylene film or the like on the outer layer of the ethylene-vinyl alcohol copolymer film in order to reduce the influence of moisture in the external atmosphere. Further, a packaging material having a large thickness such as olefin resin such as polyethylene or polypropylene, polyester, polyurethane, polyamide or the like can be used.
According to this method, a cross-linked ethylene-vinyl acetate copolymer, which easily causes blocking with the packaging material, can be used as the raw material of the plastic container.
【0022】以上のようにして製造された本発明による
薬液入りプラスチック容器は、長期の保存にも内部の薬
液の酸素での酸化等による変質が殆ど起こらない。The plastic container containing a chemical solution according to the present invention manufactured as described above hardly deteriorates due to oxidation of the internal chemical solution by oxygen even during long-term storage.
【0023】[0023]
【実施例】次に、図面に基づいて本発明を詳細に説明す
る。図1に示すように、本発明の薬液容器収納体11
は、薬液容器12、包装容器13、脱酸素容器14、薬
液15から構成される。薬液容器12は、既述の柔軟な
プラスチック材料で作製されるが、なかでも水蒸気透過
性の低い直鎖状低密度ポリエチレンが適している。この
薬液容器12は、種々の方法で作製される。例えば、直
鎖状低密度ポリエチレンのインフレーション成形によっ
て得たチューブ状のシートの一方の開放端は熱溶着し薬
液容器を懸垂するための懸垂口を設け、他方の開放端に
排出口を挿入し熱溶着する方法、直鎖状低密度ポリエチ
レンの押出成形によって得られたシート二枚を重ね合わ
せ、その周縁部を熱溶着する方法、直鎖状低密度ポリエ
チレンで上端部に小口径の排出口とそれに続く容器部を
有するブロー成形品を成形し、そのブロー成形品の側方
周縁部または/及び下方周縁部の近傍を熱溶着すること
によって得る方法等がある。これらの方法のうち、ブロ
ー成形品を用いる方法が排出口部を熱溶着していないの
で、漏れの危険性が無いので最適であり、本実施例では
この方法を用いた。既述の薬液15を排出口16から注
入する。このとき、注入する薬液15は実質的に酸素が
存在しないようにしてあり、注入する直前に薬液容器1
2内を窒素置換し、その直後薬液と窒素ガスを同時に注
入する。注入後、排出口16の開口部をプラスチック材
料で密封しゴム栓を装着し、さらにゴム栓外表面に無菌
維持するために、使用時に容易に剥離することができる
ようにプラスチックフィルムをシールする。The present invention will be described in detail with reference to the drawings. As shown in FIG. 1, the liquid medicine container housing 11 of the present invention.
Is composed of a chemical liquid container 12, a packaging container 13, a deoxidizing container 14, and a chemical liquid 15. The chemical liquid container 12 is made of the above-mentioned flexible plastic material, and linear low density polyethylene having low water vapor permeability is particularly suitable. The chemical liquid container 12 is manufactured by various methods. For example, one open end of a tubular sheet obtained by inflation molding of linear low-density polyethylene is heat-welded to provide a suspending port for suspending a drug solution container, and the other open end is provided with a discharge port for heat-insulating. Welding method, two sheets obtained by extrusion molding of linear low-density polyethylene are overlapped, and the peripheral portion is heat-welded, straight-chain low-density polyethylene with a small diameter outlet at the upper end and There is a method in which a blow-molded product having a subsequent container portion is molded, and the blow-molded product is heat-welded in the vicinity of the side peripheral edge portion and / or the lower peripheral edge portion. Of these methods, the method using a blow-molded product is most suitable because the discharge port is not heat-welded and there is no risk of leakage, and this method was used in this example. The above-mentioned chemical solution 15 is injected from the discharge port 16. At this time, the chemical solution 15 to be injected is made substantially oxygen-free, and the chemical solution container 1 is injected immediately before the injection.
The inside of 2 is replaced with nitrogen, and immediately thereafter, a chemical solution and nitrogen gas are simultaneously injected. After the injection, the opening of the discharge port 16 is sealed with a plastic material and a rubber stopper is attached, and in order to keep the outer surface of the rubber stopper aseptic, a plastic film is sealed so that it can be easily peeled off during use.
【0024】次に薬液15を収容した薬液容器12を脱
酸素剤14とともに、既述の包装容器13に入れる。こ
のとき、脱酸素剤14を片面から他面に連通する孔を有
する構造体17で覆って一緒に入れ封入する。また、包
装容器13内の気体に少なくとも50%以上の湿度をも
たせた。Next, the drug solution container 12 containing the drug solution 15 is put in the above-mentioned packaging container 13 together with the oxygen scavenger 14. At this time, the oxygen scavenger 14 is covered with a structure 17 having a hole communicating from one surface to the other surface, and is enclosed and enclosed together. Further, the gas in the packaging container 13 was made to have a humidity of at least 50% or more.
【0025】次に、この薬液容器収納体11を実質的に
酸素の存在しない水蒸気よりなる雰囲気中で高圧蒸気滅
菌する。この滅菌は、例えばオートクレーブによって行
われる。薬液容器収納体11を複数個の単位でオートク
レーブ内に収容する。ついで、ボイラーからスチームを
オートクレーブ内に所定時間導入してオートクレーブ内
の空気を排出する。排出後、所定温度のスチームをオー
トクレーブ内に導入し滅菌する。滅菌中のオートクレー
ブ内の圧力を確保するために、不活性ガスを適宜導入す
る。滅菌後、オートクレーブ内に所定量の冷却水を導入
し薬液を充分に冷却し取り出す。Next, the chemical liquid container container 11 is subjected to high-pressure steam sterilization in an atmosphere consisting of steam substantially free of oxygen. This sterilization is performed by, for example, an autoclave. The chemical liquid container housing 11 is housed in a plurality of units in the autoclave. Next, steam is introduced into the autoclave from the boiler for a predetermined time, and the air in the autoclave is discharged. After discharging, steam at a predetermined temperature is introduced into the autoclave and sterilized. An inert gas is appropriately introduced to secure the pressure in the autoclave during sterilization. After sterilization, a predetermined amount of cooling water is introduced into the autoclave to sufficiently cool the drug solution and then taken out.
【0026】図2に、本発明の別の薬液容器収納体21
を示す。薬液容器収納体21は、薬液容器22、包装容
器23、脱酸素剤24、薬液25から構成される。薬液
容器22は、図1のものと同様にブロー成形品を用いて
作製した。さらに、排出口26から薬液25を注入する
方法も図1のものと同様にして行った。FIG. 2 shows another container 21 for a liquid medicine container according to the present invention.
Indicates. The chemical liquid container housing 21 is composed of a chemical liquid container 22, a packaging container 23, an oxygen absorber 24, and a chemical liquid 25. The chemical liquid container 22 was manufactured by using a blow molded product as in the case of FIG. Further, the method of injecting the chemical solution 25 from the discharge port 26 was performed in the same manner as in FIG.
【0027】次に、薬液25を収容した薬液容器22を
実質的に酸素の存在しない水蒸気よりなる雰囲気中で高
圧蒸気滅菌する。この滅菌は、例えばオートクレーブに
よって行われる。薬液容器を複数個の単位でオートクレ
ーブ内に収容する。ついで、ボイラーからスチームをオ
ートクレーブ内に所定時間導入してオートクレーブ内の
空気を排出する。排出後、所定温度のスチームをオート
クレーブ内に導入し滅菌する。滅菌中のオートクレーブ
内の圧力を確保するために、不活性ガスを適宜導入す
る。滅菌後、オートクレーブ内に所定量の冷却水を導入
し薬液を充分に冷却する。Next, the chemical solution container 22 containing the chemical solution 25 is sterilized by high pressure steam in an atmosphere consisting of steam substantially free of oxygen. This sterilization is performed by, for example, an autoclave. A plurality of chemical solution containers are housed in the autoclave. Next, steam is introduced into the autoclave from the boiler for a predetermined time, and the air in the autoclave is discharged. After discharging, steam at a predetermined temperature is introduced into the autoclave and sterilized. An inert gas is appropriately introduced to secure the pressure in the autoclave during sterilization. After sterilization, a predetermined amount of cooling water is introduced into the autoclave to cool the drug solution sufficiently.
【0028】冷却後、既述の包装容器23に薬液容器を
入れる。このとき、窒素ガスを充填して封入する。After cooling, the chemical solution container is put in the above-mentioned packaging container 23. At this time, nitrogen gas is filled and sealed.
【0029】また図3(a),(b)に示すように、凹
凸を有する板37の上に、脱酸素剤34と薬液容器を乗
せ、包装容器33に入れることにより、脱酸素剤34の
酸素除脱効果を高めることもできる。As shown in FIGS. 3 (a) and 3 (b), the oxygen absorber 34 and the chemical solution container are placed on a plate 37 having irregularities and placed in the packaging container 33 to remove the oxygen absorber 34. It is also possible to enhance the oxygen removing effect.
【0030】実施例1 必須アミノ酸を主成分とする濃度12%のアミノ酸輸液
を、直鎖状低密度ポリエチレン製のバッグに充填した。
アミノ酸輸液中及びバッグ内を窒素置換し実質的に酸素
が存在しない状態にし、排出口を直鎖状低密度ポリエチ
レンフィルムで密封しゴム栓を装着して、その上をポリ
プロピレンとポリエチレンをブレンドした樹脂をラミネ
ートしたポリエステルフィルムで封をした。Example 1 A 12% amino acid amino acid infusion solution containing an essential amino acid as a main component was filled in a linear low-density polyethylene bag.
The amino acid infusion and the bag were replaced with nitrogen to make oxygen substantially nonexistent, the outlet was sealed with a linear low-density polyethylene film, a rubber stopper was attached, and polypropylene and polyethylene were blended on top of it. It was sealed with a laminated polyester film.
【0031】この薬液入りバッグを、二軸延伸ナイロン
フィルム(厚さ20μm)を外層としエチレン−ビニル
アルコール共重合体フィルム(厚さ20μm)を中間層
とし未延伸ポリプロピレンフィルムを内層とする三層ラ
ミネートフィルムで包装した。このとき、脱酸素剤(商
品名:エージレス 三菱瓦斯化学(株)製)を同封し、
窒素ガスを充填して脱酸素剤が薬液入りバッグと包装材
料に密着しないように封入した。この包装材料で包装さ
れた薬液入りバッグを115℃で40分間高圧蒸気滅菌
をした。滅菌時及び冷却時に圧力を保持するために、オ
ートクレーブ内に窒素ガスを所定量導入した。冷却後、
包装材料で包装された薬液入りバッグを取り出した。こ
のようにして、所望の薬液バッグ収納体を破袋すること
なく得た。This bag containing the chemical solution is a three-layer laminate having a biaxially stretched nylon film (thickness 20 μm) as an outer layer, an ethylene-vinyl alcohol copolymer film (thickness 20 μm) as an intermediate layer, and an unstretched polypropylene film as an inner layer. Wrapped in film. At this time, an oxygen absorber (trade name: Ageless Mitsubishi Gas Chemical Co., Ltd.) is enclosed.
The bag was filled with nitrogen gas and sealed so that the oxygen absorber did not come into close contact with the bag containing the liquid medicine and the packaging material. The bag containing the liquid medicine packaged with this packaging material was subjected to high-pressure steam sterilization at 115 ° C. for 40 minutes. A predetermined amount of nitrogen gas was introduced into the autoclave in order to maintain the pressure during sterilization and cooling. After cooling
The bag containing the liquid medicine packaged with the packaging material was taken out. In this way, the desired drug solution container was obtained without breaking the bag.
【0032】実施例2 実施例1と同様にして薬液入りバッグを作製した。この
薬液入りバッグを115℃で40分間高圧蒸気滅菌をし
た。滅菌時及び冷却時に圧力を保持するために、オート
クレーブ内に窒素ガスを所定量導入した。冷却後、この
薬液入りバッグを、二軸延伸ポリプロピレンフィルム
(厚さ20μm)を外層としポリ塩化ビニリデンをコー
ティングしたポリアミドフィルム(20μm)を中間層
とし未延伸ポリプロピレンフィルムを内層とする三層ラ
ミネートフィルムで包装した。このとき、脱酸素剤(商
品名:エージレス 三菱瓦斯化学(株)製)を湿度60
%の空気とともに封入して所望の薬液バッグ収納体を得
た。Example 2 A bag containing a chemical solution was prepared in the same manner as in Example 1. The bag containing the chemical solution was subjected to high-pressure steam sterilization at 115 ° C. for 40 minutes. A predetermined amount of nitrogen gas was introduced into the autoclave in order to maintain the pressure during sterilization and cooling. After cooling, this bag containing the chemical solution was a three-layer laminated film having a biaxially oriented polypropylene film (thickness 20 μm) as an outer layer, a polyvinylidene chloride-coated polyamide film (20 μm) as an intermediate layer, and an unstretched polypropylene film as an inner layer. Packaged. At this time, use a deoxidizer (trade name: Ageless Mitsubishi Gas Chemical Co., Inc.) with a humidity of 60
%, And sealed with air to obtain a desired drug solution bag container.
【0033】比較例1 脱酸素剤を用いなかったこと以外は、実施例1と同様に
して薬液バッグ収納体を得た。Comparative Example 1 A chemical solution bag container was obtained in the same manner as in Example 1 except that the oxygen absorber was not used.
【0034】比較例2 脱酸素剤が薬液入りバッグと包装材料に密着するような
形態で封入したこと以外は、実施例1と同様にして薬液
バッグ収納体を得た。Comparative Example 2 A drug solution bag container was obtained in the same manner as in Example 1 except that the oxygen absorber was sealed in such a form that it closely adhered to the drug solution containing bag and the packaging material.
【0035】比較例3 脱酸素剤が薬液入りバッグと包装材料に密着するような
形態で封入したこと以外は、実施例2と同様にして薬液
バッグ収納体を得た。Comparative Example 3 A drug solution bag container was obtained in the same manner as in Example 2 except that the oxygen absorber was sealed in such a form that it closely adhered to the drug solution-containing bag and the packaging material.
【0036】比較例4 包装材料として、二軸延伸ポリプロピレンフィルム(厚
さ20μm)を外層としエチレン−ビニルアルコール共
重合体フィルム(厚さ20μm)を中間層とし未延伸ポ
リプロピレンフィルムを内層とする三層ラミネートフィ
ルムを用いたこと以外は、実施例1と同様にして薬液バ
ッグ収納体を得た。Comparative Example 4 As a packaging material, a three-layer structure comprising a biaxially oriented polypropylene film (thickness 20 μm) as an outer layer, an ethylene-vinyl alcohol copolymer film (thickness 20 μm) as an intermediate layer and an unstretched polypropylene film as an inner layer. A drug solution bag container was obtained in the same manner as in Example 1 except that the laminate film was used.
【0037】以上のようにして得られた薬液バッグ収納
体内の薬液の変質の度合いを調べるために可視光(42
0nm)の透過率を測定し、その結果を下記に示す。In order to examine the degree of alteration of the drug solution in the drug solution bag housing obtained as described above, visible light (42
The transmittance at 0 nm) was measured, and the results are shown below.
【0038】[0038]
【表1】 [Table 1]
【0039】[0039]
(1)滅菌中及び滅菌後の保存中に酸素による容器内の
薬液の変質を防止し、安定な状態で薬液を保存すること
ができる。 (2)プラスチック製であるので、軽く運搬に便利であ
る。 (3)柔軟な薬液入りプラスチック容器は、クローズド
システムに用いることができ、空気感染を防止できる。 (4)包装材料は透明性を有するので、異物検査や保存
状態の観察等を行うのが容易である。(1) It is possible to prevent the deterioration of the drug solution in the container due to oxygen during sterilization and during storage after sterilization, and to store the drug solution in a stable state. (2) Since it is made of plastic, it is light and convenient to carry. (3) The flexible plastic container containing the drug solution can be used in a closed system and can prevent airborne infection. (4) Since the packaging material has transparency, it is easy to inspect foreign matters and observe the storage state.
【図1】本発明の酸素による薬液の変質を防止する薬液
容器収納体の一実施例を示す正面図である。FIG. 1 is a front view showing an embodiment of a chemical liquid container container for preventing the chemical liquid from being deteriorated by oxygen according to the present invention.
【図2】本発明の酸素による薬液の変質を防止する薬液
容器収納体の別の実施例を示す正面図である。FIG. 2 is a front view showing another embodiment of a container for a liquid medicine container for preventing the deterioration of the liquid medicine by oxygen according to the present invention.
【図3】(a)は本発明の酸素による薬液の変質を防止
する薬液容器収納体の別の実施例を示す正面図であり、
(b)は同実施例のIII −III 横断面図である。FIG. 3 (a) is a front view showing another embodiment of the chemical liquid container container for preventing the chemical liquid from being deteriorated by oxygen according to the present invention,
(B) is a III-III cross-sectional view of the same embodiment.
11,21,31 薬液容器収納体 12,22,32 薬液容器 13,23,33 包装容器 14,24,34 脱酸素剤 15,25,35 薬液 16,26,36 排出口 17 連通する孔を有する構造体 37 凹凸を有する板 11,21,31 Chemical liquid container container 12,22,32 Chemical liquid container 13,23,33 Packaging container 14,24,34 Deoxidizer 15,25,35 Chemical liquid 16,26,36 Discharge port 17 Has a communicating hole Structure 37 Plate with unevenness
Claims (6)
で形成された少なくとも一つ以上の排出口を有する容器
内に酸素によって変質しやすい成分を含む薬液が容器内
と薬液中の酸素を不活性ガスで置換した状態で充填され
ている薬液容器を、脱酸素剤とともに、高い酸素ガス非
透過性と耐熱性と透明性を有する包装容器に少なくとも
前記脱酸素剤の周囲に空間が存在するように封入してな
り、前記薬液容器の外側と前記包装容器の内側で構成さ
れる空間自体が薬液容器内への酸素透過を防ぐ実質的に
無酸素状態のバリアー層をなし、かつ、少なくとも薬液
容器が高圧蒸気滅菌処理されていることを特徴とする薬
液の変質を高度に防止する薬液容器収容体。1. A chemical liquid containing a component which is easily deteriorated by oxygen in a container having at least one discharge port formed of a flexible plastic material having heat resistance, and oxygen in the container and the chemical liquid is an inert gas. Enclose the chemical solution container filled with the oxygen scavenger together with the oxygen scavenger in a packaging container having high oxygen gas impermeability, heat resistance and transparency so that at least a space exists around the oxygen scavenger. The space itself constituted by the outside of the liquid medicine container and the inside of the packaging container forms a barrier layer in a substantially oxygen-free state that prevents oxygen permeation into the liquid medicine container, and at least the liquid medicine container has a high pressure. A container for a liquid medicine container, which is highly sterilized by steam and highly prevents the deterioration of the liquid medicine.
を有する構造体で覆われていることを特徴とする請求項
1に記載の薬液容器収納体。2. The liquid medicine container container according to claim 1, wherein the oxygen scavenger is covered with a structure having a hole communicating from one surface to the other surface.
るように包装容器に封入したことを特徴とする請求項1
または2に記載の薬液容器収納体。3. The oxygen absorber is enclosed in a packaging container so as to be located on a plate having irregularities.
Alternatively, the drug solution container storage body according to item 2.
たことを特徴とする請求項1に記載の薬液容器収納体。4. The drug solution container storage body according to claim 1, wherein an inert gas is simultaneously enclosed in the packaging container.
ら構成されている請求項1に記載の薬液容器収納体。5. The drug solution container storage body according to claim 1, wherein the packaging container is composed of a tray portion and a sheet-like lid body.
を放出することを特徴とする請求項1または2に記載の
薬液容器収納体。6. The drug solution container container according to claim 1, wherein the oxygen scavenger removes oxygen gas and releases carbon dioxide gas.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4315634A JPH0834729B2 (en) | 1992-11-02 | 1992-11-02 | Chemical solution container storage |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4315634A JPH0834729B2 (en) | 1992-11-02 | 1992-11-02 | Chemical solution container storage |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP61064379A Division JPS62221352A (en) | 1986-03-22 | 1986-03-22 | Liquid drug containing container preventing deterioratioan of liquid drug by oxygen and its production |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH05237162A true JPH05237162A (en) | 1993-09-17 |
JPH0834729B2 JPH0834729B2 (en) | 1996-03-29 |
Family
ID=18067726
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP4315634A Expired - Lifetime JPH0834729B2 (en) | 1992-11-02 | 1992-11-02 | Chemical solution container storage |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0834729B2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006136490A (en) * | 2004-11-11 | 2006-06-01 | Terumo Corp | Ritodrine hydrochloride injection preparation |
JP2022141824A (en) * | 2015-04-23 | 2022-09-29 | ヘマネクスト インコーポレイテッド | Anaerobic blood storage containers |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4335049B2 (en) | 2004-03-29 | 2009-09-30 | 中本パックス株式会社 | Laminated film for infusion bags |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58192552A (en) * | 1982-05-06 | 1983-11-10 | テルモ株式会社 | Package container for preserving medical container |
-
1992
- 1992-11-02 JP JP4315634A patent/JPH0834729B2/en not_active Expired - Lifetime
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58192552A (en) * | 1982-05-06 | 1983-11-10 | テルモ株式会社 | Package container for preserving medical container |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006136490A (en) * | 2004-11-11 | 2006-06-01 | Terumo Corp | Ritodrine hydrochloride injection preparation |
JP2022141824A (en) * | 2015-04-23 | 2022-09-29 | ヘマネクスト インコーポレイテッド | Anaerobic blood storage containers |
US12201584B2 (en) | 2015-04-23 | 2025-01-21 | Hemanext Inc. | Anaerobic blood storage containers |
Also Published As
Publication number | Publication date |
---|---|
JPH0834729B2 (en) | 1996-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS62221352A (en) | Liquid drug containing container preventing deterioratioan of liquid drug by oxygen and its production | |
US4998400A (en) | Medical fluid-filled plastic container and methods of making same | |
US4548605A (en) | Method for manufacturing plastic container containing infusion solution which does not allow deterioration of infusion solution for long period of time | |
JPH11276550A (en) | Package for flexible medicine container | |
AU709296B2 (en) | An ultraviolet absorbing and optically transparent packaging material | |
AU2006241992B8 (en) | Drug solution container package and method for manufacturing the same | |
US4654240A (en) | Laminate film for flexible containers | |
US20050268573A1 (en) | Package of sensitive articles | |
PT686091E (en) | AUTOCLAVAVE MULTICAMBLED MOVIES | |
JPH0116502B2 (en) | ||
JPH0525503B2 (en) | ||
JP2022167997A (en) | Plastic container, and package comprising exterior body | |
JPH05237162A (en) | Liquid chemical container housing body | |
JPH05221461A (en) | Packaging bag | |
JP5106804B2 (en) | Multilayer container manufacturing method | |
JPH07480A (en) | Manufacture of plastic container filled with medical fluid to prevent deterioration thereof by oxygen | |
JPH1080464A (en) | Transfusion vessel having gas barrier property | |
JPH10287375A (en) | Package body for container containing medicament whose properties easily change by oxygen | |
JPH0380509B2 (en) | ||
JPS6239470A (en) | Manufacture of plastic vessel containing chemical, property thereof do not change by oxygen | |
JPH03289477A (en) | Packaging bag for container receiving medicine container | |
JPH10277134A (en) | Package body of container containing an oxygen-susceptible medicine, and sterilization treatment method of the same | |
JPH1156970A (en) | Medical container | |
JPH10167341A (en) | Packaging structure for medical container | |
JP2001190639A (en) | Medical container |